270 related articles for article (PubMed ID: 26401762)
1. Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?
Banik A; Brown RE; Bamburg J; Lahiri DK; Khurana D; Friedland RP; Chen W; Ding Y; Mudher A; Padjen AL; Mukaetova-Ladinska E; Ihara M; Srivastava S; Padma Srivastava MV; Masters CL; Kalaria RN; Anand A
J Alzheimers Dis; 2015; 47(4):815-43. PubMed ID: 26401762
[TBL] [Abstract][Full Text] [Related]
2. Lost in Translation? Finding Our Way To Effective Alzheimer's Disease Therapies.
Quinn JF
J Alzheimers Dis; 2018; 64(s1):S33-S39. PubMed ID: 29758942
[TBL] [Abstract][Full Text] [Related]
3. Meeting report of the annual workshop on Principles and Techniques for Improving Preclinical to Clinical Translation in Alzheimer's Disease research.
Sasner M; Territo PR; Sukoff Rizzo SJ
Alzheimers Dement; 2023 Nov; 19(11):5284-5288. PubMed ID: 37070936
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's therapeutics: translation of preclinical science to clinical drug development.
Savonenko AV; Melnikova T; Hiatt A; Li T; Worley PF; Troncoso JC; Wong PC; Price DL
Neuropsychopharmacology; 2012 Jan; 37(1):261-77. PubMed ID: 21937983
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
Gauthier S; Leuzy A; Racine E; Rosa-Neto P
Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
[TBL] [Abstract][Full Text] [Related]
6. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
[TBL] [Abstract][Full Text] [Related]
7. Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies.
Golde TE
J Neurochem; 2016 Oct; 139 Suppl 2(Suppl 2):224-236. PubMed ID: 27145445
[TBL] [Abstract][Full Text] [Related]
8. Measuring target effect of proposed disease-modifying therapies in Alzheimer's disease.
Bateman RJ; Klunk WE
Neurotherapeutics; 2008 Jul; 5(3):381-90. PubMed ID: 18625449
[TBL] [Abstract][Full Text] [Related]
9. Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease.
Drummond E; Goñi F; Liu S; Prelli F; Scholtzova H; Wisniewski T
J Alzheimers Dis; 2018; 64(s1):S299-S312. PubMed ID: 29562516
[TBL] [Abstract][Full Text] [Related]
10. Critical Review of the Alzheimer's Disease Non-Transgenic Models: Can They Contribute to Disease Treatment?
Flores-Cuadra JA; Madrid A; Fernández PL; Pérez-Lao AR; Oviedo DC; Britton GB; Carreira MB
J Alzheimers Dis; 2021; 82(s1):S227-S250. PubMed ID: 33216029
[TBL] [Abstract][Full Text] [Related]
11. Research and standardization in Alzheimer's trials: reaching international consensus.
Carrillo MC; Rowe CC; Szoeke C; Masters CL; Ames D; O'Meara T; Macaulay SL; Milner A; Ellis KA; Maruff P; Rainey-Smith SR; Martins RN; Bain LJ; Head RJ;
Alzheimers Dement; 2013 Mar; 9(2):160-8. PubMed ID: 23266004
[TBL] [Abstract][Full Text] [Related]
12. Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials.
Castrillo JI; Lista S; Hampel H; Ritchie CW
Methods Mol Biol; 2018; 1750():31-66. PubMed ID: 29512064
[TBL] [Abstract][Full Text] [Related]
13. Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria.
Wimo A; Ballard C; Brayne C; Gauthier S; Handels R; Jones RW; Jonsson L; Khachaturian AS; Kramberger M
J Intern Med; 2014 Mar; 275(3):304-16. PubMed ID: 24605810
[TBL] [Abstract][Full Text] [Related]
14. Preventing cognitive decline in preclinical Alzheimer's disease.
Riedel WJ
Curr Opin Pharmacol; 2014 Feb; 14():18-22. PubMed ID: 24565007
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society.
Small GW; Rabins PV; Barry PP; Buckholtz NS; DeKosky ST; Ferris SH; Finkel SI; Gwyther LP; Khachaturian ZS; Lebowitz BD; McRae TD; Morris JC; Oakley F; Schneider LS; Streim JE; Sunderland T; Teri LA; Tune LE
JAMA; 1997 Oct 22-29; 278(16):1363-71. PubMed ID: 9343469
[TBL] [Abstract][Full Text] [Related]
16. Emerging concepts towards a translational framework in Alzheimer's disease.
Cozachenco D; Zimmer ER; Lourenco MV
Neurosci Biobehav Rev; 2023 Sep; 152():105246. PubMed ID: 37236385
[TBL] [Abstract][Full Text] [Related]
17. Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit.
Molinuevo JL; Cami J; Carné X; Carrillo MC; Georges J; Isaac MB; Khachaturian Z; Kim SY; Morris JC; Pasquier F; Ritchie C; Sperling R; Karlawish J
Alzheimers Dement; 2016 May; 12(5):614-22. PubMed ID: 26988427
[TBL] [Abstract][Full Text] [Related]
18. Clinical Research on Alzheimer's Disease: Progress and Perspectives.
Sun BL; Li WW; Zhu C; Jin WS; Zeng F; Liu YH; Bu XL; Zhu J; Yao XQ; Wang YJ
Neurosci Bull; 2018 Dec; 34(6):1111-1118. PubMed ID: 29956105
[TBL] [Abstract][Full Text] [Related]
19. Amyloid beta peptide immunotherapy in Alzheimer disease.
Delrieu J; Ousset PJ; Voisin T; Vellas B
Rev Neurol (Paris); 2014 Dec; 170(12):739-48. PubMed ID: 25459121
[TBL] [Abstract][Full Text] [Related]
20. The animal models of dementia and Alzheimer's disease for pre-clinical testing and clinical translation.
Anand A; Banik A; Thakur K; Masters CL
Curr Alzheimer Res; 2012 Nov; 9(9):1010-29. PubMed ID: 22698073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
